Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Haoxi Health Technology (HAO) Common Equity (2023 - 2025)

Haoxi Health Technology's Common Equity history spans 3 years, with the latest figure at $17.4 million for Q2 2025.

  • Quarterly Common Equity rose 54.16% to $17.4 million in Q2 2025 from the year-ago period, while the trailing twelve-month figure was $17.4 million through Jun 2025, up 54.16% year-over-year, with the annual reading at $17.4 million for FY2025, 54.16% up from the prior year.
  • Common Equity came in at $17.4 million for Q2 2025, up from $11.3 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $17.4 million in Q2 2025 to a low of $1.6 million in Q2 2023.
  • The 3-year median for Common Equity is $11.3 million (2024), against an average of $10.1 million.
  • Year-over-year, Common Equity skyrocketed 619.56% in 2024 and then soared 54.16% in 2025.
  • Haoxi Health Technology's Common Equity stood at $1.6 million in 2023, then surged by 619.56% to $11.3 million in 2024, then skyrocketed by 54.16% to $17.4 million in 2025.
  • Per Business Quant, the three most recent readings for HAO's Common Equity are $17.4 million (Q2 2025), $11.3 million (Q2 2024), and $1.6 million (Q2 2023).